Rare blood clots from AstraZeneca vaccine mostly affect younger people
Published
UK medicines regulator releases first breakdown by age of people who have suffered the adverse side-effect
Full ArticlePublished
UK medicines regulator releases first breakdown by age of people who have suffered the adverse side-effect
Full ArticleThe AstraZeneca adenovirus vaccine has been pulled from the market after "rare" blood clots are deemed too..
Overall, rare blood clots occurred in 93 women and 75 men aged between 18 and 93